Bruno Tremblay, who is Head of Bayer Division Crop Science for Europe Middle East Africa (EMEA), speaks in an interview in European Seed about the Access to Medicine Index, the Access to Seeds Index and the World Benchmarking Alliance.
Bayer has actively engaged in the Access to Seeds Index since it was first proposed to the seed industry by the Netherlands based NGO in 2013. Our experience is also based on contributions to the Access to Medicines Index introduced in 2008. Both indexes are an opportunity for companies to demonstrate their contributions toward specific goals as ranked and assessed through the index methodologies, which continue to evolve over time.
Access to Seeds is now part of the World Benchmarking Alliance (WBA) which is measuring and incentivizing business impact towards achieving the UN Sustainable Development Goals. The WBA is currently preparing a new Food and Agriculture benchmark involving over 300 companies. In this new Index, ten of the highest revenue companies from both fertilizers, agrochemicals and seed suppliers were selected to be included. WBA will publish further details on the benchmark’s methodology and begin its baseline in 2020 (see www.worldbenchmarkingalliance.org).
Read full article on European Seed